Effect of filtration leukocytapheresis therapy: Modulation of white blood cell enzyme activities in patients with rheumatoid arthritis

Artificial Organs

Volumn 26, Issue 4, 2002, Pages 378-384

  Yamasaki, Satoshi ^a,b   Ueki, Yukitaka ^a   Nakamura, Hideki ^a   Yano, Mayumi ^a   Matsumoto, Kazunari ^a   Miyake, Seibei ^a   Tominaga, Tan ^a   Tominaga, Masaya ^a   Eguchi, Katsumi ^b  

^a SASEBO CHUO HOSPITAL   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dipeptidylpeptidase IV; Elastase; Filtration leukocytapheresis; Granulocyte; Lymphocyte; Monocyte; Rheumatoid arthritis

Indexed keywords

DISEASES; ENZYMES; MODULATION; PATIENT TREATMENT;

CLINICAL RESPONSE; DIPEPTIDYLPEPTIDASE IV; ELASTASE; ENZYMES ACTIVITY; FILTRATION LEUCOCYTAPHERESIS; GRANULOCYTE; LEUCOCYTES; MONOCYTE; RHEUMATOID ARTHRITIS; WHITE BLOOD CELLS;

LYMPHOCYTES;

DIPEPTIDYL PEPTIDASE IV; ELASTASE; LEUKOCYTE ENZYME;

ADULT; AGED; ARTICLE; CALCULATION; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE; ENZYME ACTIVITY; FEMALE; FILTRATION; GRANULOCYTE; HUMAN; LEUKAPHERESIS; LEUKOCYTE COUNT; LYMPHOCYTE; MALE; MONOCYTE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

EID: 0036240061     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.2002.06834.x     Document Type: Article

References (25)

1. The immunopathology of joint inflammation in rheumatoid arthritis
2. Mononuclear phagocytes and rheumatoid synovitis: Masterhorse in arthritis?
3. The role of T cells in the immunopathogenesis of rheumatoid arthritis
4. Lymphapheresis in rheumatoid arthritis: A randomized trial
5. Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate
6. Evaluation of filtration leukocytapheresis (LCP) for use in the treatment of patients with rheumatoid arthritis
7. Filtration leukocytapheresis therapy in rheumatoid arthritis: A randomized, double-blind, placebo-controlled trial
8. Degradation of human articular cartilage by neutrophils in synovial fluid
9. Elastase and collagenase activities in synovial fluid of patients with arthritis
10. Degradation in vivo of articular cartilage in rheumatoid arthritis and juvenile chronic arthritis by cathepsin G and elastase from polymorphonuclear leukocytes
11. Ta1, a novel 105kd human T cell activation antigen defined by a monoclonal antibody
12. Increment of Ta1 positive cells in peripheral blood from patients with rheumatoid arthritis
13. Cytofluorographic evidence that thymocyte dipeptidyl peptidase IV (CD26) activity is altered with stage of ontogeny and apoptotic status
14. Increased population of high fluorescence 1F7 (CD26) antigen on T cells in synovial fluid of patients with rheumatoid arthritis
15. Antigen reactive memory T cells are defined by Ta1
16. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
17. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis
18. Identification of known and novel genes in activated monocytes from patients with rheumatoid arthritis
19. The mechanism of the efficiency of leukocytapheresis on rheumatoid arthritis
20. The tissue architecture of synovial membranes in inflammatory and non-inflammatory joint diseases
21. Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy
22. Evidence for recent as well as long term activation on T cells migrating through endothelial cell monolayers in vitro
23. Phenotypic characterization of CD4+ T cells that exhibit a transendothelial migratory capacity
24. Clinical and immunologic effects of fractionated total lymphoid irradiation in refractory rheumatoid arthritis
25. Interleukin-2 diphtheria fusion protein (DAB486IL-2) in refractory rheumatoid arthritis: A double-blind, placebo-controlled trial with open-label extension